Articles by Caroline Harris

Caroline Harris

Caroline Harris is a third-year student at Capilano University in North Vancouver, Canada. Having already completed an Associates Degree in Psychology, Caroline is now finishing her Bachelor's degree in Communications. In preparation for working in the advertisement sector, Caroline is writing financial content and analysis. On a daily basis, Caroline works on articles regarding the following topics: finance, cryptocurrency, technology, and politics.

IPATF stock

IPATF Stock Soars: Subsidiary Receives Exclusive License from Stanford

Apr 26 Caroline Harris

On Friday, April 26, ImmunoPrecise Antibodies’ subsidiary U-Protein Express disclosed that it’s obtained an exclusive license from Stanford University. The license allows U-Protein Express to manufacture and sell Wnt surrogate Fc. On the news, IPATF ... [Read]

ATOS stock

ATOS Stock Plunges Despite CEO Presenting at Boston Breast Cancer Summit

Apr 25 Caroline Harris

On April 23, ATOS stock was up nearly 30% ahead of today’s presentation by Atossa Genetics’ CEO Steven Quay at the Precision: Breast Cancer World R&D Summit in Boston. It’s now the day of the ... [Read]

AKTX stock

AKTX Stock Flying after Announcing Positive Phase 2 Clinical Trial Data

Apr 23 Caroline Harris

Akari Therapeutics (NASDAQ:AKTX) is making headlines after the biopharmaceutical company announced positive data from a Phase 2 clinical trial. The news, released today, sent AKTX stock up nearly 20% at the time of writing. AKTX ... [Read]

MBRX stock

MBRX Stock Up 150% on Moleculin Lung Cancer Discovery

Apr 22 Caroline Harris

Moleculin Biotech (NASDAQ:MBRX) has got investors on the edge of their seats. On Monday, April 22, the company said it made a “significant discovery” for lung cancer and will be discussing it on a conference ... [Read]

MBIO stock

MBIO Stock Skyrockets More than 100% Today and Here’s Why

Apr 18 Caroline Harris

What an incredible two days it has been for Mustang Bio (NASDAQ:MBIO). On Wednesday, April 17, the company announced that it entered a licensing agreement with St. Jude Children’s Research Hospital to develop the lentiviral ... [Read]

RWLK stock

RWLK Stock Up Nearly 20%: ReWalk Announces First Personal Exoskeleton

Apr 16 Caroline Harris

In 2016, a New York man was in a motorcycle accident, and he injured his spinal cord as a result. Today, ReWalk Robotics (NASDAQ:RWLK) announced that this same man received a ReWalk Personal 6.0 exoskeleton. ... [Read]

HMNY stock

HMNY Stock Down 55% After MoviePass Parent Reports $6M Financing Round

Mar 26 Caroline Harris

On Tuesday, March 26th, Helios and Matheson Analytics (OTC:HMNY) said it raised money in a new round of financing. The total came to $6 million. Despite having justifiable plans for the funds, HMNY stock dropped considerably ... [Read]

ALT stock

ALT Stock Down Despite Altimmune Releasing Positive Trial Results

Mar 20 Caroline Harris

After soaring on Tuesday, ALT stock is trading down nearly 10% on Wednesday. Yesterday’s results came after Altimmune Inc. (NASDAQ:ALT) announced positive Phase 2 results for its flu vaccine candidate. ALT Stock Today On March ... [Read]

DERM stock

DERM Stock Up 100% After Dermira Announces Positive Trial Results

Mar 18 Caroline Harris

DERM stock is starting Monday off with a bang. After Dermira, Inc. (NASDAQ:DERM) announced news of a positive trial of dermatitis treatment, shares of the biotech company soared. At the time of writing, DERM stock ... [Read]

AMAG stock

AMAG Stock Closes Down 17% After Failed Phase 3 Trial

Mar 8 Caroline Harris

On Friday, March 8th, AMAG Pharmaceuticals (NASDAQ:AMAG) made an announcement that sent the AMAG stock into the red. The stock ended up closing the trading day down nearly 20%. Here’s what we know. AMAG Pharmaceuticals ... [Read]

x